- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05575089
Inspiratory Muscle Training and Pulmonary Function in Patients Submitted to Bariatric Surgery
Pre-operative Inspiratory Muscle Training Effectiveness and Pulmonary Function in Patients Submitted to Bariatric Surgery
Study Overview
Status
Conditions
Detailed Description
This is a controlled and randomized clinical trial that included 106 patients. The protocol was approved by the ethics committee (4.395.114; CAAE: 39118720.4.0000.0064).
Inclusion and exclusion criteria The sample consisted of patients for bariatric surgery from an outpatient clinic who were referred to physiotherapy by the medical team to be submitted to the preoperative protocol. The inclusion criteria are as follows: age over 18 years, body body mass index (BMI) ≥35 kg/m2, indication for elective bariatric surgery by videolaparoscopy. The patients would be excluded if they presented hemodynamic instability (systolic blood pressure [SBP] ˂ 90mmhg or reduction greater than 40mmhg; mean blood pressure [MAP] ˂ 65mmhg; tachycardia: heart rate ˃ 100bpm; altered level of consciousness; tachypnea: respiratory rate [RR] > 18rpm; and urine output: diuresis < 0.5ml/kg/hr)17. Furthermore, patients who were not release from their health insurance to undergo the surgery, were not included in the study.
Randomization Patients will be randomized into two blocks with 42 patients each, therefore two treatment groups: control and intervention groups. Randomization will be performed by a researcher not involved in the recruitment or treatment of the patients through a random draw in Excel software. Opaque sealed envelopes were used to ensure blind randomization. The envelopes will be kept in a safe place and delivered to the responsible physiotherapist after the initial assessments. Before starting the intervention, the envelope will be opened by the researcher, revealing the group strategy (control or intervention).
Assessments Preoperative procedures The patients will be evaluated clinically and demographically by the same evaluator and had their data recorded: level of physical activity (time per week); musculoskeletal pain based on the visual analogue scale (VAS)18; cough peak flow (CPF) by a peak flow meter19; dyspnea (modified Borg scale)20; maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP) by a manovacuometer21; respiratory symptoms, such as dyspnea and cough; and vital signs, including systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), respiratory rate (RR), and pulse oxygen saturation (SpO2). All the patients will be submitted to a preoperative spirometry in order to exclude previous pulmonary diseases, and, at the end of the evaluation, the patients were randomized into the control group (CG) or the intervention group (IG). All patients will be underwent to 10 preoperative physiotherapy sessions, and the preoperative evaluations took place during the first and at the end of the 10th session.
Preoperative protocol The preoperative exercise protocol will be performed in both groups under a physiotherapist's supervision in 10 non-consecutive sessions in an outpatient setting twice a week, on average 30 days before the surgical procedure. The protocol consist of diaphragmatic breathing and lung re-expansion exercises, including fractional inspiration, maximum sustained inspiration and pursed lips strategy. All respiratory exercises will be performed associated with upper limb exercises and involved three sets of 10 repetitions each. Aerobic exercise will be performed on a treadmill or cycle ergometer for 20 minutes, with the load and speed set according to the individualized prescription for each patient. During the interval between the 10 sessions, the patients in both groups will be also instructed to perform standardized exercises daily at home until the moment before surgery. Pre- and postoperative instructions will be provided by the same physiotherapist that will be the responsible for the entire perioperative period. In addition to guidelines related to the surgical procedure, the patients will be instructed to perform respiratory physiotherapy according to preoperative guidance (control or intervention group) and to wear elastic socks before, during, and after surgery. All patients will be asked to keep a diary about the proposed activities.
Control group The patients will be performed all exercises in the preoperative protocol (breathing and aerobic exercises) in addition to incentive spirometry (Respiron®) in sets of 30 repetitions (level 1), 40 repetitions (level 2), or 50 repetitions (level 3) according to their weekly evolution. It will be recommended that the patients perform incentive spirometry at home, with a frequency of three times a day and an intensity as described above.
Intervention group The IMT will be associated to the same exercises offered in the preoperative protocol (breathing and aerobic exercises). It will be performed with Powerbreathe®, (Medic Plus mechanical model), with 60% of the obtained maximum inspiratory pressure in the first preoperative physical therapy evaluation. Powerbreathe®, a muscle training device, will be available to the patients, and they were instructed to also perform 30 repetitions at home three times a day.
In the immediate postoperative period, all patients will be kept for 24 hours in the intensive care unit (ICU). In addition to the guidance received about coughing, walking, and exercise practices for the lower limbs to prevent deep venous thrombosis, all patients will be performed exercises with an incentive spirometer, every hour, 30 times, and will be remained seated between intervals. As soon as possible, they will walk around the inpatient unit accompanied by the physiotherapist. Before hospital discharge (1st PO) and on the 30th postoperative day (30th PO), the patients will return to outpatient clinic to be evaluated for pain, dyspnea, MIP, MEP, CPF, and vital signs (SBP, DBP, HR, RR, and SpO2). Pulmonary complications in the period will be checked.
Statistical analysis The sample calculation was obtained from a previous study by Lloréns et al. (2015), who evaluated inspiratory muscle strength in clinically severe patients with obesity undergoing bariatric surgery after an IMT program22. A mean MIP difference of 12 (±2) cmH2O was detected between groups (sample power = 80%, alpha error = 5%, sample loss = 15%, 42 patients per group). The variables will be previously tested in relation to their distribution. Mixed linear models will be used to analyze the differences obtained between groups and to assess the intragroup evolution, a two-factor analysis of variance (ANOVA) (time and group) will be used for the following variables: MIP and MEP, CPF, and pain. Statistical Package for the Social Sciences for Windows (SPSS) version 23.0 will be used for the analysis, and a value of 5% was considered for rejection of the null hypothesis in all tests.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Minas Geraes
-
Pouso Alegre, Minas Geraes, Brazil, 37558-443
- Centro de Reabilitação Stimullus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Accept to participate in the study
- Age over 18 years
- Any gender
- Elective bariatric surgery
Exclusion Criteria:
Mechanical ventilation for more than 48 hours after the surgical procedure
- Hemodynamic instability at the time of the first evaluation and persistent in the evaluation after 1 hour
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Incentive Spirometer - The Control Group
The control group will receive an aerobic exercise in the cycle ergometer that will be conducted on a cycle ergometer divided into three steps: heat 5 minutes; 20 minutes with a confortable speed ( individuallyprescribed) and 5 minutes recovery.
They will also perform active respiratory exercises, and incentive spirometer during 10 face-to-face physical therapy sessions.
They will be instructed to do exercises with incentive spirometer at home, 3 times a day with 30 to 40 repetitions, during all preoperative period.
The patients will receive a diary to note the exercises frequency.
|
10 face-to-face non consecutive sessions with 30 minutes in a cycle ergometer(divided into three steps: heat 5 minutes; 20 minutes with a comfortable and supportable speed or load ( individually prescribed) and 5 minutes recovery
Diaphragmatic exercises ( deep inspirations) associated to raise upper limbs ( 3 times - 10 repetitions each)
|
|
Experimental: Inspiratory muscle training - Powerbreath - The intervention group
This intervention group will receive the same control group protocol: aerobic exercise in cycle ergometer, divided into three steps: heat 5 minutes; 20 minutes with a confortable speed ( individually prescribed) and 5 minutes recovery and active respiratory exercises ( deep inspirations associated to raise upper limbs ( 3 times of 10 repetitions each), and, in addition, inspiratory muscle training with Powerbreath during 10 face-to-face physical therapy sessions.
They will be instructed to do exercises with Powerbreath at home, 3 times a day with 30 to 40 repetitions, inspiratory load: 60% of MIP ( first evaluation - protocol admission) during all preoperative period.
The patients will receive a diary to note the exercises frequency.
|
10 face-to-face non consecutive sessions with 30 minutes in a cycle ergometer(divided into three steps: heat 5 minutes; 20 minutes with a comfortable and supportable speed or load ( individually prescribed) and 5 minutes recovery
Diaphragmatic exercises ( deep inspirations) associated to raise upper limbs ( 3 times - 10 repetitions each)
The device "Powerbreath" is an inspiratory muscle training used to train respiratory muscles.
Currently, it is one of the most used devices for the TMI, a linear load model with continuous application of inspiratory pressure throughout inspiration, in which the inspiratory regulating valve remains open while allowing an unrestricted expiration that generates resistance through a spring or of an electronic valve system, ability to offer greater load during training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change over time in Inspiratory muscle strength - maximum inspiratory pressure (MIP)
Time Frame: All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
To measure MIP, patients will be instructed to perform a maximal inspiratory effort from residual volume (RV), using a previously calibrated analog manovacuometer (range +/- 300cmH20).
The highest value obtained after three repetitions will be recorded.
The obtained values will be compared to the predicted values ( Predicted equations by Neder et al.)
|
All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
|
Change over time in Expiratory muscle strength - maximum expiratory pressure (MEP)
Time Frame: All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
To measure MEP, patients will be instructed to perform a maximal expiratory effort from total lung capacity (TLC) using a previously calibrated analog manovacuometer (range +/- 300cmH20).
The highest value obtained after three repetitions will be recorded.
The obtained values will be compared to the predicted values ( Predicted equations by Neder et al.)
|
All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
|
Change over time in Peak Cough Flow (PCF)
Time Frame: All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
For PCF measurements, you will be asked to the patients to cough with maximum effort after a deep inspiration using a peak flow meter.
The highest value obtained from three repetitions will be recorded.
The obtained values will be compared to the predicted values for healthy Brazilian population.
|
All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change over time in Pain
Time Frame: All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
The pain will be measured by visual numeric scale (VNS).
The scale ranges from 0 to 10, with 10 being the worst possible pain.
|
All patients will be assessed at baseline ( protocol admission), in the 10th session of preoperative protocol ( average 30 days), 1st postoperative day ( average 7 days after the last pre op.session) and 30th postoperative day ( 30 days after surgery)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Luciana Chiavegato, PHD, Federal University of São Paulo
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UNICID2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle Weakness
-
St. Luke's-Roosevelt Hospital CenterCompletedFall Risk | Quadriceps Muscle Weakness | Adductor Muscle WeaknessUnited States
-
Lactomason Co., Ltd.RecruitingAge-Related Muscle WeaknessSouth Korea
-
Healthbiome IncCompletedAge-Related Muscle WeaknessSouth Korea
-
Eastern Mediterranean UniversityCompletedPelvic Floor Muscle WeaknessCyprus
-
University of Central ArkansasCompletedPelvic Floor Muscle WeaknessUnited States
-
Ludwig Boltzmann Institute of Electrical Stimulation...Medical University of Vienna; European Union; Comenius University; Ministry of...CompletedMuscle Weakness Condition | Therapy EffectAustria, Slovakia
-
Association Pro-arteActive, not recruitingWeakness, Muscle | AmyotrophiaFrance
-
Rutgers, The State University of New JerseyRecruitingPhysical Disability | Muscle Atrophy or Weakness | Muscle Loss | Physical Inactivity | Delirium in Old Age | Hospital Acquired Condition | Weakness, MuscleUnited States
-
Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie...CompletedMuscle Weakness | Muscle Weakness Condition | CopdRomania
-
University of Central FloridaCompletedMuscle Weakness | Muscle Atrophy | Muscle Loss | Weakness, Muscle | Injury, KneeUnited States
Clinical Trials on Aerobic exercise in cycle ergometer
-
Centro Universitario La SalleUniversidad Rey Juan CarlosNot yet recruiting
-
Universidade Católica de PelotasUnknown
-
Bursa Yuksek Ihtisas Training and Research HospitalCompletedExercise to Improve Sleep and Quality of Life in Stroke Patients Receiving Botulinum Toxin TreatmentHemiplegia and/or Hemiparesis Following StrokeTurkey (Türkiye)
-
Federal University of Health Science of Porto AlegreUnknownLymphoma | Leukemia | Fatigue | Multiple Myeloma | Hematopoietic Stem Cell TransplantationBrazil
-
Turku University HospitalUnknownGlymphatic System | NeurodegenerationFinland
-
The Hong Kong Polytechnic UniversityRecruiting
-
Brennan ThompsonWithdrawnPost Activation PotentiationUnited States
-
University of Sao PauloWithdrawnCardiac Surgery | Exercise Movement TechniquesBrazil
-
Federal University of São PauloUnknownPhysical Activity | Coronary Artery Bypass Graft Triple Vessel | Acute Myocardial Infarction: Rehabilitation PhaseBrazil
-
Oberwaid AGUniversity of Zurich; University of Basel; Institute for Exercise and Health...CompletedDepression | Sleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep Fragmentation | Insomnia Due to Other Mental Disorder | Insomnia, Psychophysiological | Insomnia Related to Another Mental ConditionSwitzerland